Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don’t yet have steady revenue streams because their new drug or treatment is still in development, hasn’t received FDA approval, or hasn’t been in the market long enough to establish a proven...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.